Autoimmune hemolytic anemia (AIHA) is a rare disorder in which a person's immune system mistakenly attacks and destroys their own red blood cells. This can lead to anemia, a decrease in red blood cells, and other serious health complications. While there is no cure for AIHA, treatment options are available to manage the condition and reduce symptoms.
Symptoms of Autoimmune Hemolytic Anemia
The most common symptom of AIHA is a decrease in red blood cells, which can lead to anemia. Other symptoms may include fatigue, shortness of breath, pale skin, dizziness, and jaundice.
Diagnosis of Autoimmune Hemolytic Anemia
A diagnosis of AIHA is usually made after a physical exam and laboratory tests. A complete blood count (CBC) can measure the number of red blood cells in the body, and a test called a Coombs test can detect antibodies that are attacking the red blood cells.
Treatment of Autoimmune Hemolytic Anemia
Treatment for AIHA typically involves medications that suppress the immune system. Corticosteroids, such as prednisone, are often used to reduce the number of antibodies attacking the red blood cells. Other medications, such as immunosuppressants, may be prescribed to help control the body's immune response. In some cases, a blood transfusion may be necessary to replenish the supply of red blood cells.
Prognosis of Autoimmune Hemolytic Anemia
The prognosis for AIHA depends on the severity of the condition. In some cases, the disorder may go into remission and the patient can live a normal life. In other cases, the disorder may require ongoing treatment and monitoring to prevent serious complications.
